Notes on test equality in stratified noncompliance randomized trials

被引:2
作者
Lui, Kung-Jong [1 ]
机构
[1] San Diego State Univ, Coll Sci, Dept Math & Stat, San Diego, CA 92182 USA
来源
DRUG INFORMATION JOURNAL | 2007年 / 41卷 / 05期
关键词
type I error; power; noncompliance; stratified randomized trials;
D O I
10.1177/009286150704100507
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In randomized clinical trials, we often encounter the situations in which there are some patients who do not comply with their assigned treatments and also some confounders that are needed to control in assessing a treatment effect. To account for both noncompliance and confounders, we developed four asymptotic test procedures: (1) the test procedures based on the risk difference (RD) using the intention-to-treat approach with the optimal weight derived by the weighted least squares method; (2) the test procedure based on the instrumental variable (IV) estimator for the RD with the corresponding weighted least squares optimal weight; (3) the test procedure based on the IV estimator for the RD with tanh(-1) (x) transformation; and (4) the test procedure based on the Mantel-Haenszel estimator for the RD using the intention-to-treat approach. We apply Monte Carlo simulation to evaluate the finite sample performance of these test procedures in a variety of situations. Except for the test procedure using tanh(-1) (x) transformation, all the other procedures can perform well with respect to type I error even when the mean stratum size is moderate. We further find that when the mean stratum size is moderate, the test procedure based on IV estimator directly is generally preferable to the others with respect to power subject to maintaining type I error less than or approximately equal to the nominal a-level. When both the probability of compliance and the mean stratum size are large, however, we find that the test procedure based on IV estimator with tanh(-1) (x) transformation is more powerful than the others without losing the accuracy of type I error. Finally, we use the data taken from afield trial of studying the effect of a multifactor intervention program on the mortality incidence from coronary heart disease in middle-aged men to illustrate the practical use of these test procedures.
引用
收藏
页码:607 / 618
页数:12
相关论文
共 33 条
  • [1] Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
  • [2] [Anonymous], 2004, STAT ESTIMATION EPID
  • [3] BERNHARD G, 1989, BIOMETR J, V31, P29
  • [4] BRUNNER E, 1985, METHOD INFORM MED, V24, P120
  • [5] Casella G., 2021, Statistical inference
  • [6] Cochran WG., 1963, SAMPLING TECHNIQUES
  • [7] Durbin J., 1954, REV INT STAT I, V22, P23, DOI [DOI 10.2307/1401917, 10.2307/1401917]
  • [8] EDWARDES MDD, 1995, BIOMETRICS, V51, P571
  • [9] Fisher LD., 1990, Statistical Issues in Drug Research and Development
  • [10] ESTIMATION OF A COMMON EFFECT PARAMETER FROM SPARSE FOLLOW-UP DATA
    GREENLAND, S
    ROBINS, JM
    [J]. BIOMETRICS, 1985, 41 (01) : 55 - 68